Pacific Biosciences of California Capital Reinvestment Ratio
Pacific Biosciences of California capital reinvestment ratio. Pacific Biosciences of California (PACB) has a Capital Reinvestment Ratio of 0.00x as of March 2020, meaning it reinvests 0% of its operating cash flow ($75.36 Million) in capital expenditures ($117.00K). Check Pacific Biosciences of California (PACB) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Pacific Biosciences of California (2020–2020)
Capital reinvestment ratio of Pacific Biosciences of California from 2020 to 2020. This chart tracks Pacific Biosciences of California's Capital Reinvestment Ratio across 1 annual periods. Also explore PACB net asset momentum to track the company's year-over-year net asset growth rate.
Pacific Biosciences of California Capital Reinvestment Ratio by Year (2020–2020)
Pacific Biosciences of California capital reinvestment ratio by year from 2020 to 2020. For the full cash flow conversion analysis, see PACB cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.05x | $19.50 Million | $1.04 Million | — |